Supplementary Figure 6 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer Darren A.E. Cross , Susan E. Ashton , Serban Ghiorghiu , Cath Eberlein , Caroline A. Nebhan , Paula J. Spitzler , Jonathon P. Orme , M. Raymond V. Finlay , Richard A. Ward , Martine J. Mellor , Gareth Hughes , Amar Rahi , Vivien N. Jacobs , Monica Red Brewer , Eiki Ichihara , Jing Sun , Hailing Jin , Peter Ballard , Katherine Al-Kadhimi , Rachel Rowlinson , Teresa Klinowska , Graham H.P. Richmond , Mireille Cantarini , Dong-Wan Kim , Malcolm R. Ranson , William Pao crossref（2023）
摘要
PDF file - 312KB, Efficacy of AZD9291 in H3255, PC-9VanR and A431 xenograft models. Weight loss data for chronically dosed AZD9291 in PC-9 and H1975 xenograft models.
更多 查看译文
AI 理解论文
溯源树
样例
